A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects

NCT07301333 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain

Interventions

DRUG: HRS-6257
DRUG: placebo

Sponsor

Shanghai Hengrui Pharmaceutical Co., Ltd.